Compounds > 3,3',5,5'-tetrachlorobiphenyl-4,4'-diol
Page last updated: 2024-08-26

3,3',5,5'-tetrachlorobiphenyl-4,4'-diol and idarucizumab

3,3',5,5'-tetrachlorobiphenyl-4,4'-diol has been researched along with idarucizumab in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almeida, MR; Almeida, ZL; Brito, RMM; Cardoso, AL; Costa, D; Jesus, CSH; Pinho E Melo, TMVD; Saraiva, MJ; Simões, CJV1

Other Studies

1 other study(ies) available for 3,3',5,5'-tetrachlorobiphenyl-4,4'-diol and idarucizumab

ArticleYear
A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition.
    European journal of medicinal chemistry, 2016, Oct-04, Volume: 121

    Topics: Amyloid; Drug Design; Furans; Hep G2 Cells; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Prealbumin; Protein Aggregates; Protein Conformation; Protein Stability

2016